Reyataz and Deafness transitory partial - from FDA reports


There is no Deafness transitory partial reported by people who take Reyataz yet. This review analyzes which people have Deafness transitory partial with Reyataz. It is created by eHealthMe based on reports from FDA, and is updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).



On Oct, 18, 2018

No report is found.



Do you have Deafness transitory partial while taking Reyataz?


You are not alone:




Related studies

Reyataz

Reyataz has active ingredients of atazanavir sulfate. It is often used in hiv infection. (latest outcomes from Reyataz 9,170 users)

Deafness Transitory Partial

Deafness transitory partial (deafness temporary-partial) (latest reports from 3 Deafness transitory partial patients).


Drugs that are associated with Deafness transitory partial
Deafness transitory partial
Could your condition cause Deafness transitory partial
Deafness transitory partial
Reyataz side effects
Browse all side effects of Reyataz
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Reyataz and have Deafness transitory partial


Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.